Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone

1990, The Danish Verapamil Infarction Trial (DAVIT) II, Am J Cardiol, 66, 779 1990, Secondary prevention with verapamil after myocardial infarction, Am J Cardiol, 66, 33I, 10.1016/0002-9149(90)91262-5 1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure, Lancet, 342, 821 Køober, 1995, A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after acute myocardial infarction, N Engl J Med, 333, 1670, 10.1056/NEJM199512213332503 Packer, 1990, Calcium channel blockers in chronic heart failure. The risk of “physiologically” rational therapy, Circulation, 82, 2254, 10.1161/01.CIR.82.6.2254 Messerli, 1990, “Cardioprotection”—not all calcium antagonists are created equal, Am J Cardiol, 66, 855, 10.1016/0002-9149(90)90364-7 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 Ambrosioni, 1995, The effect of angiotensin converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction, N Engl J Med, 332, 80, 10.1056/NEJM199501123320203 Moyé, 1994, Uniformity of captopril benefit in the SAVE study: subgroup analysis, Eur Heart J, 15, 2, 10.1093/eurheartj/15.suppl_B.2 Kornowski, 1993, Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction, Am J Cardiol, 72, 883, 10.1016/0002-9149(93)91100-V Ball, 1994, ACE inhibition, atherosclerosis and myocardial infarction—the AIRE study in practice, Eur Heart J, 15, 20, 10.1093/eurheartj/15.suppl_B.20